ResMed Inc. (RMD): Price and Financial Metrics

ResMed Inc. (RMD)

Today's Latest Price: $173.88 USD

2.12 (-1.20%)

Updated Feb 21 12:00am

Add RMD to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

RMD Stock Summary

  • Resmed Inc's market capitalization of $22,821,733,443 is ahead of 91.13% of US-listed equities.
  • Price to trailing twelve month operating cash flow for RMD is currently 39.81, higher than 90.98% of US stocks with positive operating cash flow.
  • With a year-over-year growth in debt of 146.52%, Resmed Inc's debt growth rate surpasses 89.9% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Resmed Inc are BCPC, LSBK, LPT, TCX, and CNS.
  • Visit RMD's SEC page to see the company's official filings. To visit the company's web site, go to
RMD Daily Price Range
RMD 52-Week Price Range

RMD Stock Price Chart More Charts

RMD Price/Volume Stats

Current price $173.88 52-week high $177.99
Prev. close $176.00 52-week low $96.81
Day low $173.54 Volume 448,200
Day high $175.70 Avg. volume 495,709
50-day MA $161.73 Dividend yield 0.9%
200-day MA $138.33 Market Cap 25.15B

ResMed Inc. (RMD) Company Bio

ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders with a focus on sleep-disordered breathing. The company was founded in 1989 and is based in San Diego, California.

RMD Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$173.88$27.93 -84%

We started the process of determining a valid price forecast for Resmed Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Resmed Inc ranked in the 16st percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for RMD, they are:

  • The company's debt burden, as measured by earnings divided by interest payments, is 13.19 -- which is good for besting 73.75% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
  • The business' balance sheet suggests that 5% of the company's capital is sourced from debt; this is greater than merely 17.1% of the free cash flow producing stocks we're observing.
  • RMD's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 52.18% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Resmed Inc? See AMPH, HAE, PKI, QGEN, and ZBH.

RMD Latest News Stream

Event/Time News Detail
Loading, please wait...

RMD Latest Social Stream

Loading social stream, please wait...

View Full RMD Social Stream

RMD Price Returns

1-mo 7.32%
3-mo 19.11%
6-mo 28.51%
1-year 73.67%
3-year 153.47%
5-year 189.37%
YTD 12.45%
2019 37.85%
2018 36.38%
2017 39.06%
2016 18.01%
2015 -2.29%

RMD Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full RMD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7562 seconds.